Profil wykonawcy
MERCK SHARP & DOHME, LDA
PT- Zamówienia
- 24
- Łączna wartość zamówień
- 22 043 380 €
- Kraje
- countries.PT
- Ostatnie zamówienie
- 12 maj 2026
- Wygasają w ciągu 12 miesięcy
- 0
Historia zamówień
| Data | Zamawiający | Tytuł | Kategoria | Wartość | Kraj | Wygasa | Źródło |
|---|---|---|---|---|---|---|---|
| 12.05.2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Immune sera and immunoglobulins – 2024/0963 - VACINA CONTRA O VÍRUS DO PAPILOMA HUMANO NONAVALENTE (HPV9) [DOSE] | — | 489,7 tys. € | PT | — | Zobacz w TED ↗ |
| 12.05.2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - PEMBROLIZUMAB [25 MG/ ML 4 ML SOL INJ FRS] | — | 1,5 mln € | PT | — | Zobacz w TED ↗ |
| 19.03.2026 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – IMUNOMODULADORES - PEMBROLIZUMAB | — | 437,3 tys. € | PT | — | Zobacz w TED ↗ |
| 23.12.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0671 - LETERMOVIR [240 MG CÁP/COMP] | — | 392,3 tys. € | PT | — | Zobacz w TED ↗ |
| 23.12.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0671 - LETERMOVIR [240 MG CÁP/COMP] | — | 91,7 tys. € | PT | — | Zobacz w TED ↗ |
| 02.09.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Immune sera and immunoglobulins – 2022/0013- VACINA CONTRA O VÍRUS DO PAPILOMA HUMANO NONAVALENTE (HPV9) [DOSE] | — | 522,5 tys. € | PT | — | Zobacz w TED ↗ |
| 19.08.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2024/0900 - DORAVIRINA [100 MG; COMP] | — | 274,6 tys. € | PT | — | Zobacz w TED ↗ |
| 05.08.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2024/0900 - RALTEGRAVIR [600 MG; CÁP/ COMP] | — | 274,9 tys. € | PT | — | Zobacz w TED ↗ |
| 05.08.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2024/0900 - RALTEGRAVIR [600 MG; CÁP/ COMP] | — | 58,1 tys. € | PT | — | Zobacz w TED ↗ |
| 22.07.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0671 - CEFTOLOZANO + TAZOBACTAM [1 G + 0.5 G; PÓ CONC SOL INJ; IV; FRS] | — | 65,2 tys. € | PT | — | Zobacz w TED ↗ |
| 22.07.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0671 - CEFTOLOZANO + TAZOBACTAM [1 G + 0.5 G; PÓ CONC SOL INJ; IV; FRS] | — | 324,5 tys. € | PT | — | Zobacz w TED ↗ |
| 01.07.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Medicinal products for the cardiovascular system – 2023/0305 - RIOCIGUAT [2.5 MG; CÁP/COMP] | — | 77,4 tys. € | PT | — | Zobacz w TED ↗ |
| 01.07.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Medicinal products for the cardiovascular system – 2023/0305 - RIOCIGUAT [2.5 MG; CÁP/COMP] | — | 387,0 tys. € | PT | — | Zobacz w TED ↗ |
| 17.06.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2024/0900 - RALTEGRAVIR [400 MG; CÁP/COMP] | — | 249,7 tys. € | PT | — | Zobacz w TED ↗ |
| 17.06.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2024/0900 - RALTEGRAVIR [400 MG; CÁP/COMP] | — | 1,0 mln € | PT | — | Zobacz w TED ↗ |
| 28.05.2025 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – IMUNOMODULADORES - PEMBROLIZUMAB | — | 470,3 tys. € | PT | — | Zobacz w TED ↗ |
| 15.04.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - Medicamentos do foro oncológico e imunomoduladores (P1330) | — | 6,9 mln € | PT | — | Zobacz w TED ↗ |
| 15.04.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Blood products – 2023/0491 - PEMBROLIZUMAB [25 MG/ ML;4 ML; SOL INJ; FRS] (P1330) | — | 1,4 mln € | PT | — | Zobacz w TED ↗ |
| 27.03.2025 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – IMUNOMODULADORES - PEMBROLIZUMAB - 1 MES | — | 470,3 tys. € | PT | — | Zobacz w TED ↗ |
| 04.12.2024 | SERVIÇO DE SAUDE DA REGIAO AUTONOMA DA MADEIRA | Portugal – Various medicinal products – BEAD20240009- VACINAS - PNV | — | 1,2 mln € | PT | — | Zobacz w TED ↗ |
| 12.11.2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – LETERMOVIR 240 MG COMP | — | 487,7 tys. € | PT | — | Zobacz w TED ↗ |
| 03.10.2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/491 - Medicamentos do foro oncológico e imunomoduladores (P1330) | — | 3,3 mln € | PT | — | Zobacz w TED ↗ |
| 15.05.2024 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – IMUNOMODULADORES - PEMBROLIZUMAB - 1 (UM) MÊS | — | 313,5 tys. € | PT | — | Zobacz w TED ↗ |
| 15.04.2024 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – IMUNOMODULADORES - GOLIMUMAB E PEMBROLIZUMAB - 1º SEMESTRE | — | 1,4 mln € | PT | — | Zobacz w TED ↗ |